Skip to content
Recall Observatory FDA recall evidence

Drug product

Duloxetine Delayed-Release Capsules, USP, 60mg, 1,000-count bottles, Rx Only, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Distributed by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-748-10.

D-0552-2025

July 15, 2025

Class II

Product summary

Firm
Breckenridge Pharmaceutical, Inc.
Event
Event 97276
Status
Ongoing
Classification
Class II
Quantity
1,829 60-count bottles
Official record key
drug-enforcement:D-0552-2025

Official wording

Reason: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above safety assessment limit

Code information: Lot: 230836C, Exp.: 02/28/2026

Distribution pattern: U.S Nationwide

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    N-nitroso-duloxetine impurity
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations